Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme targets involved in cell signaling pathways. Commonly employed in medicinal chemistry for constructing pyrrolopyrimidine-based drug candidates with antitumor and anti-inflammatory activities. Also utilized in research settings to develop novel bioactive molecules through functional group modifications at the ester and heterocyclic positions.